Skip to main content
. Author manuscript; available in PMC: 2017 Jul 7.
Published in final edited form as: Cardiovasc Drugs Ther. 2016 Dec;30(6):559–566. doi: 10.1007/s10557-016-6695-9

Table 2.

Heart rate (beats/minute) and blood pressure (mmHg) at different time point (n=15 in each group)

Time point Saline group Low dose group High dose Group p value
Heart rate
  1 287 ± 6 286 ± 8 274 ± 7 NS
  2 281 ± 9 273 ± 9 264 ± 7 NS
  3 275 ± 7 277 ± 9 267 ± 7 NS
  4 280 ± 5 284 ± 6 268 ± 7 NS
  5 287 ± 6 292 ±8 272 ± 9 NS
Systolic blood pressure
  1 90 ± 4 90 ± 4 84 ± 3 NS
  2 75 ± 2 75 ± 3 70 ± 2 NS
  3 78 ± 3 84 ± 4 70 ± 2 0.037*
  4 70 ± 2 84 ± 5 69 ± 3 0.016*
  5 70 ± 3 76 ± 5 70 ±4 NS
Diastolic blood pressure
  1 68 ± 3 70 ± 4 62 ± 3 NS
  2 55 ± 2 56 ± 2 50 ± 2 NS
  3 56 ± 2 62 ± 2 47 ± 2 <0.001
  4 49 ± 2 60 ± 2 46 ± 2 0.007*
  5 47 ± 2 53 ± 4 45 ± 2 NS

Time point: at (1) 5 minutes prior coronary artery occlusion; (2) 1 minute prior to coronary artery reperfusion; (3) 1 hour after reperfusion; (4) 2 hours after reperfusion; (5) 3 hours after reperfusion. NS: not significant.

*

Low dose vs. high dose.

High dose vs. low dose and saline.